Ahammune Biosciences
PrivateLast Round
Series A
Sep 25, 2024
Total Funding Raised
$5M
Company Overview
Ahammune Biosciences operates in Healthcare & Life Sciences and is based in Pune. Its latest recorded funding round was a Series A round in September 2024.
Ahammune Biosciences is a biotechnology company that develops small molecule-based therapeutics for the treatment of immune-mediated skin diseases, with a primary focus on vitiligo.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ahammune Biosciences Comparables
Compare Ahammune Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yarrow Bioscience, Inc. | 78% | |
| Edesa Biotech Inc | 72% | |
| Incyte Corporation | 71% |
For institutional investors. Book with your work email.
Ahammune Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 25, 2024 | ||||
| Early Funding | Apr 26, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ahammune Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IAN Group | Series A, Early Funding |
| pi Ventures | Series A |
| Colossa Ventures | Series A |
| Ideaspring Capital | Series A, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 4390% MoM.
- Apr 26, 2021
Led by IAN Group and Ideaspring Capital.
For institutional investors. Book with your work email.
Ahammune Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ahammune Biosciences's valuation, stock price, and market status.
Is Ahammune Biosciences a public or private company?
Ahammune Biosciences is a private company.
What is the current stock price of Ahammune Biosciences?
Ahammune Biosciences is a private company, so its shares have no public market price. Caplight tracks Ahammune Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ahammune Biosciences worth (valuation)?
Valuation information for Ahammune Biosciences is not publicly available.
Can I buy Ahammune Biosciences stock?
Ahammune Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ahammune Biosciences's last funding round?
Ahammune Biosciences's most recent funding round was Series A on September 25, 2024.
Who are the main investors in Ahammune Biosciences?
Key investors in Ahammune Biosciences include IAN Group, pi Ventures, Ideaspring Capital.
Will Ahammune Biosciences IPO soon?
No public IPO plans have been announced for Ahammune Biosciences.
How can I track Ahammune Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Ahammune Biosciences's shares on secondary markets.